How exactly do you know that Lympro has done nothing so
How exactly do you know that Lympro has done nothing so far? They told us about the first collaboration, but that doesn't necessarily mean there aren't other deals already made or on the horizon. You've got to start somewhere. You saying it's worthless is no different than me saying it's worth billions. Neither of us have real evidence to back either of our claims. Wait for the next update, possibly after the next data presentation, before you draw the conclusion that Lympro is worthless.
Also, if you weren't expecting some lag time between deals being struck and revenue being generated from Lympro, then you were fooling yourself to begin with.
They have said all along that there is competition out there. The main goal was to be first to market, which they were. Lympro is not just Lympro anymore either. They are attempting to package the different diagnostics together to offer a suite of tests that will increase the accuracy and value of the whole package.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Bunge Limited Faces Market Pressures as Stock Prices Decline In a year characterized by considerable market fluctuations, Bunge Limited (NYSE: BG) has seen its stock reach a concerning 52-week low of $77.52. With an attractive price-to-earnings (P/E) ratio of 9.7 and a commendable dividend yield of 3.48%, Bunge has consistently paid dividends for an impressive 24 years,...
Continue Reading
Upcoming Market Highlights to Observe As we look ahead, several significant events are poised to influence market dynamics. As corporate earnings season blossoms, attention will focus on major players in tech, finance and energy sectors. Global leaders are gathering to discuss critical economic issues, all while fluctuating oil prices add to the tension. Let's explore...
Continue Reading
Touchmark Bancshares, Inc. just cut ties with the Office of the Comptroller of the Currency (OCC) on February 17, 2026, after a lengthy 22-month oversight period. This enforcement action was slapped on them back in April 2024, and it seemed like a cloud hanging over their heads for ages. Traders were watching closely—this termination isn’t just a footnote; it speaks...
Continue Reading
Bybit Kicks Off an Innovative WSOT 2025 Bybit, a leading player in the cryptocurrency exchange arena, is taking bold steps to redefine the World Series of Trading (WSOT) in its upcoming 2025 edition. Known for hosting the longest-running crypto trading competition globally, Bybit is set to catapult this event into a new era, offering a staggering 10 million USDT prize...
Continue Reading
Brookfield Corporation to Host Second Quarter 2025 Results Conference Call BROOKFIELD, NEWS — Brookfield Corporation (NYSE: BN) will host its second quarter 2025 conference call and webcast on Thursday, August 7, 2025, at 10:00 AM (ET). Key Information and Joining Details Results from the financial quarter will be released that morning around 7:00 AM (ET) and will be...
Continue Reading
